Biocryst Pharmaceuticals buy TD Cowen
Start price
15.10.25
/
50%
€5.62
Target price
15.10.26
€25.82
Performance (%)
35.15%
Price
27.04.26
€7.60
Summary
This prediction is currently active. With a performance of 35.15% the BUY prediction by TD_Cowen is a big success. This prediction currently runs until 15.10.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -2.515% | -2.515% |
| iShares Core DAX® | -1.424% | 8.918% |
| iShares Nasdaq 100 | 3.274% | 16.275% |
| iShares Nikkei 225® | 1.745% | 16.239% |
| iShares S&P 500 | 1.447% | 10.913% |
Comments by TD_Cowen for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat